Literature DB >> 14985815

On the use of mixtures of organotin species for catalytic enantioselective ketone allylation--a detective story.

Anthony Cunningham1, Vijaya Mokal-Parekh, Claire Wilson, Simon Woodward.   

Abstract

In the presence of enantiopure MTBH(2)(monothiobinaphthol, 2-hydroxy-2[prime or minute]mercapto-1,1[prime or minute]-binaphthyl; 0.2 eq.) quantitative allylation of ArC([double bond]O)Me takes place with impure Sn(CH(2)CH[double bond]CH(2))(4)(prepared from allyl chloride, air-oxidised magnesium and SnCl(4)) to yield tert-homoallylic alcohols in 85-92% ee. In the same process highly purified, or commercial, Sn(CH(2)CH[double bond]CH(2))(4) yields material of only 35-50% ee. The origin of these effects is the presence of small amounts of the compounds, EtSn(CH(2)CH[double bond]CH(2))(3), ClSn(CH(2)CH[double bond]CH(2))(3) ClSnEt(CH(2)CH[double bond]CH(2))(2) in the tetraallyltin sample and the presence of traces of water (which inhibits achiral background reactions). All the triallyl and diallyl species enhance the stereoselectivity in the catalytic allylation reaction, the chlorides more so than the ethyl compound. Hydrolysis of ClSnEt(CH(2)CH[double bond]CH(2))(2) affords crystallographically characterised Sn(4)(mu(3)-O)(mu(2)-Cl)(2)Cl(2)Et(4)(CH(2)CH[double bond]CH(2))(4). Reaction of this latter compound with MTBH(2) leads to the most potent catalyst.

Entities:  

Year:  2004        PMID: 14985815     DOI: 10.1039/b313384b

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  2 in total

1.  Catalytic asymmetric methallylation of ketones with an (H8-BINOLate)Ti-based catalyst.

Authors:  Jeung Gon Kim; Elizabeth H Camp; Patrick J Walsh
Journal:  Org Lett       Date:  2006-09-28       Impact factor: 6.005

2.  The mechanism and an improved asymmetric allylboration of ketones catalyzed by chiral biphenols.

Authors:  David S Barnett; Philip N Moquist; Scott E Schaus
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.